Evidence map›Paper›PMID 40018912›Full record

ArticleVeterinary surgery : VS2025

Improvement in short-term outcome over time, in a single center embarking on a canine mitral valve repair program using a structured multidisciplinary approach.

Daniel J Brockman, Thomas D Greensmith, Matteo Rossanese, Alison Young, Sarah L Carey, Adrian Boswood, Thaleia-Rengina Stathopoulou, Carolina Palacios Jimenez, Nigel Cross

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Veterinary surgery : VS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Daniel J BrockmanRoyal Veterinary College, University of London, London, UK.ORCID https://orcid.org/0000-0002-2133-9500
Thomas D GreensmithRoyal Veterinary College, University of London, London, UK.
Matteo RossaneseRoyal Veterinary College, University of London, London, UK.ORCID https://orcid.org/0000-0001-8884-4088
Alison YoungRoyal Veterinary College, University of London, London, UK.
Sarah L CareyRoyal Veterinary College, University of London, London, UK.
Adrian BoswoodRoyal Veterinary College, University of London, London, UK.
Thaleia-Rengina StathopoulouRoyal Veterinary College, University of London, London, UK.
Carolina Palacios JimenezRoyal Veterinary College, University of London, London, UK.
Nigel CrossRoyal Veterinary College, University of London, London, UK.

Funding

Tailwaggers Club to the Royal Veterinary College
6 · The paper itself

Abstract

objectiveTo describe a structured approach to the development of a mitral valve repair (MVR) program for dogs with myxomatous mitral valve disease (MMVD) and to document the change in short term outcome over time. STUDY

designClinical prospective study. ANIMALS: Dogs (n = 132) with MMVD undergoing MVR at a single hospital.

methodsUsing a carefully structured multidisciplinary approach to patient selection, surgical treatment, and postoperative care that incorporated both "reflective" and "deliberate" practice, we embarked on an MVR program alongside our pre-existing open heart surgery program. Data were gathered for the first 132 dogs undergoing MVR in this program (between July 2015 and November 2022). Short-term survival was defined as dogs that were discharged from the hospital. The dogs were divided into four groups of equal size based on chronological order and the data within each group compared using descriptive statistics.

resultsThe breeds most represented were Cavalier King Charles Spaniels (CKCS) and Chihuahuas. The MMVD was categorized clinically as stage D in 36/132 (27%), stage C in 88/132 (67%) and stage B2 in 8/132 (6%) of affected dogs. Overall, 107/132 (81%) of the dogs survived to discharge. A consistent trend of improved short-term outcome was observed, with survival rate of 22/33 in the first quartile, 27/33 in the second quartile, 28/33 in the third quartile, and 30/33 dogs in the fourth quartile.

conclusionA structured organized approach by a team of consistent personnel resulted in an improvement in outcome over time. This improvement most likely reflected improvement in both technical and non-technical skills within this complex sociotechnical environment. CLINICAL SIGNIFICANCE: What constitutes an acceptable performance for MVR in the dog has not been defined so the number of cases that constitute the "learning curve" during program development and the number of cases required in the "skills maintenance" phase remain unknown. The data reported here, however, describe the level of organizational commitment and the case throughput required to begin the process of establishing a successful MVR program and as such, should be useful to any team considering this therapy.

Indexed as

Dog DiseasesMitral ValveMitral Valve InsufficiencyAnimalsDogsFemaleMaleProspective StudiesTreatment Outcome

Identifiers

PMID40018912
PMCPMC12063714

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.